Increased radiation toxicity with germline ATM variant of uncertain clinical significance

Brandon T. Mullins; Gaorav Gupta

doi:10.1016/j.rpor.2019.09.008

Vol 24, No 6 (2019)

Published online: 2019-11-01

Submitted: 2019-05-24

View PDF

Download PDF file

Get Citation

Increased radiation toxicity with germline ATM variant of uncertain clinical significance

Brandon T. Mullins, Gaorav Gupta

DOI: 10.1016/j.rpor.2019.09.008

Rep Pract Oncol Radiother 2019;24(6):672-680.

Vol 24, No 6 (2019)

Published online: 2019-11-01

Submitted: 2019-05-24

Abstract

Background

While patients with ataxia telangiectasia are known to have increased radiation sensitivity, patients with germline heterozygous ataxia telangiectasia mutated (ATM) mutations can have widely varying functional and clinical effects, which can make management decisions difficult. With an increased prevalence of gene panel-based testing for breast cancer patients, radiation oncologists are increasingly confronted with patients who carry germline ATM variants of uncertain clinical significance. This study describes the clinical courses and outcomes of 5 breast cancer patients with varying germline heterozygous ATM mutations undergoing radiation therapy at our institution in order to provide additional knowledge of the varying clinical effects to aid future decision making.

Case Series

We identified 5 patients with breast cancer and varying germline heterozygous ATM mutations treated at the University of North Carolina Hospitals between 2015 and 2017. The median age at breast cancer diagnosis for the patient series was 46. Clinical effects of radiation treatment varied amongst the 5 patients. The one patient with a pathogenic ATM mutation had no increased radiation related toxicity. Of the 4 patients with ATM variants of uncertain significance, one patient had increased radiation sensitivity with Grade 3 dermatitis. All patients have remained recurrence free with a median duration of 18 months.

Conclusion

Our data illustrates that patients with germline heterozygous ATM mutations can have widely varying clinical effects with radiation therapy. Given the possibility of unpredictable deleterious effects, our study highlights the importance of caution and careful consideration when devising the multi-modality management strategy in these patients.